Page 849 - Read Online

Page 8 of 8 Burches et al. J Cancer Metastasis Treat 2019;5:63 I http://dx.doi.org/10.20517/2394-4722.2019.012

2. Hesterberg P, Banerji A, Oren E, Penson RT, Krasner CN, et al. Risk stratification for desensitization of patients with carboplatin
hypersensitivity: clinical presentation and management. J Allergy Clin Immunol 2009;123:1262-7.
3. Pujade-Lauraine E. How to approach patients in relapse.Ann Oncol 2012;23:x128-31.
4. Leddermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, et al. Newly diagnosed and relapsed epithelial ovarian
carcinoma: ESMO Clinical Practice Guidelines for diagnosis treatment and follow-up. Ann Oncol 2013;24:vi24-32.
5. Du Bois A, Luck H-J, Meier W, Adams H-P, Mobus V, et al. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel
as first-line treatment of ovarian cancer. J Nat Cancer Inst 2003;95:1320-30.
6. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004;114:371-6.
7. Makrilia N, Syrigou E, Kaklamanos I, Manolopoulos L, Wasif Saif W. Hypersensitivity reactions associated with platinum antineoplastic
agents: a systematic review. Met Based Drugs 2010; 2010:207084.
8. Jones R, Ryan M, Friedlander M. Carboplatin hypersensitivity reactions: retreatment with cisplatin desensitization. Gynecol Oncol
2003;89:112-5.
9. Kandel MJ, Loehr A, Harter P, Traut A, Ganuert K, et al. Cisplatinum rechallenge in relapsed ovarian cancer patients with platinum
reinduction therapy and carboplatin hypersensitivity. Int J Gynecol Cancer 2005;15:780-4.
10. Ottaiano A, Tambaro R, Greggi S, Prato R, Di Maio M, et al. Safety of cisplatin after sever hypersensitivity reactions to carboplatin in
patients with recurrent ovarian carcinoma. Anticancer Res 2003;23:3465-8.
11. Dizon DS, Sabbatini PJ, Aghajanian C, Hensley ML, Spriggs DR. Analysis of patients with epithelial ovarian cancer or fallopain tube
carcinoma retreated with cisplatin after the development of a carboplatin allergy. Gynecol Oncol 2002;84:378-82.
12. Castells MC, Tennant TN, Sloane DE, Ida Hsu F, Barret NA, et al. Hypersensitvity reactions to chemotherapy: outcomes and safety or rapid
desensitization in 413 cases. J Allergy Clin Immunol 2008;122:574-80.
13. Castells M. Rapid desensitization for hypersensitivity reactions to medications. Immunol Allergy Clin 2009;29:585-606.
14. Goldberg A, Confino-Cohen R, Fishman A, Beyth Y, Altaras M, et al. A modified prolonged desensitization protocol in carboplatin allergy. J
Allergy Clin Immunol 1996;98:841-843.
15. Morales AR, Shah N, Castells M. Antigen-IgE desensitization in signal transducer and activator of tra nscription 6-deficient-mast cells by
suboptimal doses of antigen. Ann Allergy Asthma Immunol 2005;94:575-80.